Stock GNS GENUS PLC
Add to a list
To use this feature you must be a member
Log inSign up

Financials Genus plc

Equities

GNS

GB0002074580

Biotechnology & Medical Research

Market Closed - London S.E.
Other stock markets
 11:35:13 2024-06-25 EDT 		5-day change 1st Jan Change
1,672 GBX -3.24% Intraday chart for Genus plc -0.12% -22.95%
05-27 Genus Power Infrastructures Forms Subsidiary MT
05-02 Genus Power Infrastructures Forms New Subsidiary for Smart Metering Project MT

Valuation

Fiscal Period: June 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 1,707 2,285 3,221 1,634 1,417 1,096 - -
Enterprise Value (EV) 1 1,787 2,387 3,327 1,819 1,612 1,328 1,305 1,284
P/E ratio 223 x 57.1 x 68.9 x 40.3 x 42.9 x 40 x 24.5 x 19.1 x
Yield 1.05% 0.82% 0.65% 1.28% 1.48% 1.93% 2.06% 2.29%
Capitalization / Revenue 3.49 x 4.14 x 5.61 x 2.75 x 2.05 x 1.63 x 1.54 x 1.46 x
EV / Revenue 3.66 x 4.33 x 5.79 x 3.07 x 2.34 x 1.97 x 1.83 x 1.72 x
EV / EBITDA 23.6 x 24 x 31.5 x 18.2 x 14.6 x 12.8 x 10.8 x 9.67 x
EV / FCF 110 x 67.8 x 85.7 x -233 x 88.6 x 65.3 x 22.8 x 22.3 x
FCF Yield 0.91% 1.47% 1.17% -0.43% 1.13% 1.53% 4.38% 4.49%
Price to Book 3.32 x 4.51 x 6.48 x 2.84 x 2.47 x 1.89 x 1.81 x 1.72 x
Nbr of stocks (in thousands) 64,472 64,685 64,941 65,168 65,404 65,564 - -
Reference price 2 26.48 35.32 49.60 25.08 21.66 16.72 16.72 16.72
Announcement Date 19-09-05 20-09-08 21-09-09 22-09-08 23-09-07 - - -
1GBP in Million2GBP
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 488.5 551.4 574.3 593.4 689.7 674.3 711.4 748.5
EBITDA 1 75.6 99.3 105.5 99.9 110.6 103.5 121.2 132.8
EBIT 1 57.7 65.3 76.9 68.8 74.6 67.41 85.3 98.2
Operating Margin 11.81% 11.84% 13.39% 11.59% 10.82% 10% 11.99% 13.12%
Earnings before Tax (EBT) 1 9.9 51.5 55.8 48.4 39.4 40.11 62.66 76.25
Net income 1 7.8 40.5 47.3 40.9 33.3 29.59 47.05 57.29
Net margin 1.6% 7.34% 8.24% 6.89% 4.83% 4.39% 6.61% 7.65%
EPS 2 0.1190 0.6190 0.7200 0.6220 0.5050 0.4181 0.6813 0.8750
Free Cash Flow 1 16.3 35.2 38.8 -7.8 18.2 20.34 57.21 57.7
FCF margin 3.34% 6.38% 6.76% -1.31% 2.64% 3.02% 8.04% 7.71%
FCF Conversion (EBITDA) 21.56% 35.45% 36.78% - 16.46% 19.65% 47.21% 43.44%
FCF Conversion (Net income) 208.97% 86.91% 82.03% - 54.65% 68.73% 121.58% 100.72%
Dividend per Share 2 0.2770 0.2910 0.3200 0.3200 0.3200 0.3232 0.3449 0.3826
Announcement Date 19-09-05 20-09-08 21-09-09 22-09-08 23-09-07 - - -
1GBP in Million2GBP
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: June 2020 S1 2024 S1
Net sales 1 270.7 333.6
EBITDA 47.4 -
EBIT 34.4 -
Operating Margin 12.71% -
Earnings before Tax (EBT) 30.4 -
Net income - -
Net margin - -
EPS 0.3630 -
Dividend per Share 2 0.0940 0.1030
Announcement Date 20-02-27 24-02-22
1GBP in Million2GBP
Estimates

Balance Sheet Analysis

Fiscal Period: June 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 79.6 103 106 185 196 232 209 188
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 1.053 x 1.033 x 1.001 x 1.852 x 1.77 x 2.243 x 1.721 x 1.417 x
Free Cash Flow 1 16.3 35.2 38.8 -7.8 18.2 20.3 57.2 57.7
ROE (net income / shareholders' equity) 10% 11.1% 13.2% 10.1% 9.63% 7.39% 9.56% 10.8%
ROA (Net income/ Total Assets) 0.97% - - - - 3.86% 5.35% 6.13%
Assets 1 806.7 - - - - 767.2 880.2 934.3
Book Value Per Share 2 7.980 7.840 7.650 8.850 8.770 8.860 9.210 9.750
Cash Flow per Share 2 0.5100 1.010 1.030 0.5200 0.7600 0.6100 0.9800 1.190
Capex 1 17.1 24.6 28.7 42.1 35.2 29.8 21.6 23.1
Capex / Sales 3.5% 4.46% 5% 7.09% 5.1% 4.42% 3.04% 3.09%
Announcement Date 19-09-05 20-09-08 21-09-09 22-09-08 23-09-07 - - -
1GBP in Million2GBP
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Genus plc

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
16.72 GBP
Average target price
27.78 GBP
Spread / Average Target
+66.16%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
GENUS PLC Stock Genus plc
-22.95% 1.39B
MODERNA, INC. Stock Moderna, Inc.
+38.36% 52.73B
LONZA GROUP AG Stock Lonza Group AG
+36.73% 39B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-8.63% 38.52B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
+25.46% 30.38B
CELLTRION, INC. Stock Celltrion, Inc.
-11.17% 26.39B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+11.44% 26.08B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+45.09% 14.15B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+32.93% 12.6B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
-5.30% 11.51B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. GNS Stock
  4. Financials Genus plc